amiodarone has been researched along with Neuromuscular Diseases in 7 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with sinuatrial disease and implanted pacemaker was treated with amiodarone (maximum dose 1000 mg, maintenance dose 800 mg daily) for 10 months, for control of supraventricular tachyarrhythmias." | 7.67 | Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. ( Clarke, B; Honey, M; Ward, DE, 1985) |
| "A patient with sinuatrial disease and implanted pacemaker was treated with amiodarone (maximum dose 1000 mg, maintenance dose 800 mg daily) for 10 months, for control of supraventricular tachyarrhythmias." | 3.67 | Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy. ( Clarke, B; Honey, M; Ward, DE, 1985) |
| "Amiodarone is an antiarrhythmic medication with many side effects." | 1.56 | Amiodarone-induced neuromyopathy in a geriatric patient. ( Leung, G; Pearce, P; Samii, L; Stanton, MM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Stanton, MM | 1 |
| Samii, L | 1 |
| Leung, G | 1 |
| Pearce, P | 1 |
| Flanagan, EP | 1 |
| Harper, CM | 1 |
| St Louis, EK | 1 |
| Silber, MH | 1 |
| Josephs, KA | 1 |
| Bonnet, C | 1 |
| Zabraniecki, L | 1 |
| Bertin, P | 1 |
| Viger, B | 1 |
| Fauquez-Cotillon, C | 1 |
| Couratier, P | 1 |
| Vallat, JM | 1 |
| Trèves, R | 1 |
| Meier, C | 1 |
| Kauer, B | 1 |
| Müller, U | 1 |
| Ludin, HP | 1 |
| Carella, F | 1 |
| Riva, E | 1 |
| Morandi, L | 1 |
| Cappiello, E | 1 |
| Mangoni, A | 1 |
| Anderson, NE | 1 |
| Lynch, NM | 1 |
| O'Brien, KP | 1 |
| Clarke, B | 1 |
| Ward, DE | 1 |
| Honey, M | 1 |
7 other studies available for amiodarone and Neuromuscular Diseases
| Article | Year |
|---|---|
Amiodarone-induced neuromyopathy in a geriatric patient.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electromyography; Female | 2020 |
Amiodarone-associated neuromyopathy: a report of four cases.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electromyography; Female; Follow-Up | 2012 |
Amiodarone-induced neuromyopathy mimicking polymyositis.
Topics: Aged; Amiodarone; Diagnosis, Differential; Humans; Male; Neuromuscular Diseases; Polymyositis; Vasod | 1995 |
Neuromyopathy during chronic amiodarone treatment. A case report.
Topics: Aged; Amiodarone; Benzofurans; Humans; Iodine; Male; Microscopy, Electron; Muscles; Neuromuscular Di | 1979 |
Myopathy during amiodarone treatment: a case report.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Biopsy; Electromyography; Female; Heart Ventricles; Humans; | 1987 |
Disabling neurological complications of amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Biopsy; Electromyography; Female; Gait; Humans; Male; Muscle Hypotoni | 1985 |
Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy.
Topics: Adult; Amiodarone; Atrial Fibrillation; Atrial Flutter; Benzofurans; Combined Modality Therapy; Exer | 1985 |